Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3018562	li-neut	% (%)	205	330	0.00%
3018562	li-neut	— (—)	112	115	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other neurological diseases

149

106

11.08

123.38

1.7

1.2

43.22

34.90

0.92

Aneurysms, operations, SAH

25.00

88.23

2.2

1.2

53.04

20.00

2.74

Nontraumatic intracranial haemmorrhage

22.20

87.04

2.2

1.2

54.05

18.94

3.36

Cerebrovascular diseases

105

119

6.21

53.45

1.8

1.2

48.41

33.85

1.98

Intracranial trauma

22.05

49.58

1.2

42.00

23.29

—

Cerebrovascular diseases (FINNGEN)

10.18

48.93

2.0

1.4

50.61

21.00

3.97

Headache

115

6.19

47.88

1.7

1.4

38.02

39.40

0.09

STROKE

7.15

47.50

1.9

1.3

46.93

26.73

2.79

Concussion

20.69

43.62

1.2

35.85

23.29

—

Stroke, including SAH

109

5.80

42.23

2.0

1.2

51.72

33.60

2.68

Neurological diseases

10.71

40.69

1.5

1.4

31.40

42.10

0.62

Symptoms and signs involving the nervous and musculoskeletal systems

151

5.31

40.15

1.5

1.4

37.51

38.35

0.05

106

Sequelae of cerebrovascular disease

7.58

37.95

1.9

1.2

47.06

29.29

1.67

Bleeding

163

4.19

32.54

1.8

1.3

51.86

32.30

4.20

General examination and investigation of persons without complaint and reported diagnosis

5.71

29.14

1.6

1.4

42.43

35.56

0.49

Other symptoms and signs involving the nervous and musculoskeletal systems

5.21

25.21

1.7

1.5

43.33

31.80

1.06

Focal epilepsy, strict definition

8.88

25.02

1.8

1.2

29.63

39.19

0.44

Focal epilepsy

8.44

24.83

1.8

1.2

29.62

38.57

0.42

Epilepsy

6.24

23.83

1.7

1.6

31.06

32.03

0.04

Examination and observation for other reasons

5.17

22.89

1.3

1.4

42.21

35.56

0.40

Focal epilepsy, mode (most common among epilepsy diagnosis)

8.31

22.22

1.8

1.2

25.71

35.52

0.47

General symptoms and signs

124

3.56

21.23

1.4

1.3

35.05

38.50

0.25

Fever of other and unknown origin

104

4.45

20.67

1.5

1.3

34.84

38.75

0.24

Symptoms and signs involving cognition, perception, emotional state and behaviour

192

3.16

20.20

1.5

1.4

36.10

36.73

0.04

133

Implicit viral Sepsis

8.14

19.61

1.2

1.3

40.11

40.89

0.02

Viral Sepsis

7.90

19.13

1.2

40.11

38.74

0.04

Organic, including symptomatic, mental disorders

4.28

18.92

1.1

1.4

46.24

42.23

0.22

Other symptoms and signs involving cognitive functions and awareness

4.42

18.65

1.8

1.3

43.69

35.92

0.48

Sciatica+with lumbago

127

3.77

16.85

1.4

37.94

38.15

0.01

Lower back pain or/and sciatica

213

2.76

16.13

1.4

1.5

41.47

36.81

0.40

144

Other headache syndromes

4.26

15.63

1.3

1.6

43.27

37.58

0.32

Malaise and fatigue

4.03

15.00

1.4

1.3

45.41

39.51

0.32

Abnormalities of gait and mobility

15.39

14.37

1.3

1.2

28.22

33.10

—

Dorsalgia

156

2.75

13.45

1.2

1.5

35.85

37.91

0.13

109

Other and unspecified polyneuropathies, also in other diseases

6.07

13.37

1.2

1.3

21.79

39.76

0.92

Cervicobrachial syndrome

5.57

13.34

2.0

1.3

37.00

41.29

0.16

Implicit viral Sepsis

4.56

13.25

1.4

1.5

39.35

34.98

0.19

Migraine

3.75

13.06

1.7

1.5

39.17

35.51

0.20

Implicit Sepsis

165

2.88

12.79

1.3

1.5

42.30

38.67

0.23

110

Injuries to the head

215

2.49

12.67

1.3

1.5

42.10

36.57

0.51

143

Dizziness and giddiness

168

2.88

12.54

1.5

1.4

40.16

38.32

0.11

117

Low back pain

155

2.87

12.37

1.4

1.5

45.17

38.11

0.53

108

Stroke, excluding SAH

120

3.17

12.25

1.9

1.4

47.09

37.62

0.85

Episodal and paroxysmal disorders

146

2.69

12.24

1.3

1.5

32.92

38.61

0.47

Hard cardiovascular diseases

139

2.83

12.16

1.7

1.5

41.78

38.01

0.27

Other soft tissue disorders, not elsewhere classified

165

2.63

11.87

1.4

35.24

37.22

0.13

117

Condition for Implicit Sepsis (Organ dysfunction codes)

185

2.57

11.14

1.3

1.6

37.61

38.80

0.07

127

Implicit Sepsis

181

2.63

11.09

1.3

1.6

40.61

38.69

0.12

121

Pain, not elsewhere classified

4.71

10.69

1.2

1.3

31.00

30.29

0.02

Anxiety disorders, excluding more controls

151

2.67

10.62

1.5

34.46

35.07

0.04

107

Medical observation and evaluation for suspected diseases and conditions

3.46

10.53

1.1

1.4

42.88

35.56

0.39

Primary_lymphoid and hematopoietic malignant neoplasms

4.62

10.45

1.5

1.2

19.29

37.77

1.27

Implicit bacterial Sepsis

3.40

10.27

1.3

1.5

43.59

37.56

0.31

Other mental disorders due to brain damage and dysfunction and to physical disease

10.59

10.25

1.3

1.2

50.45

40.36

0.27

Persons encountering health services for specific procedures and health care

209

2.32

10.24

1.6

1.4

39.55

37.96

0.11

140

Polyneuropathies and other disorders of the peripheral nervous system

4.70

10.22

1.2

1.3

21.79

34.77

0.62

Complications of surgical and medical care, not elsewhere classified

222

2.35

10.15

1.7

1.4

42.54

36.15

0.65

142

Intracranial injury

162

2.75

9.35

1.2

1.5

41.21

38.69

0.14

106

Pain in limb

160

2.51

9.22

1.5

1.4

43.82

37.29

0.51

112

Visual disturbances

141

2.91

9.19

1.8

1.4

27.69

36.13

0.58

Visual disturbances and blindness

152

2.83

9.16

1.8

1.3

26.67

39.74

1.10

Other bacterial diseases

206

2.28

9.15

1.3

1.5

37.82

38.07

0.02

137

Other dorsopathies, not elsewhere classified

156

2.38

9.15

1.4

1.5

31.78

37.91

0.46

109

Certain infectious and parasitic diseases

133

2.49

9.14

1.2

1.6

24.91

44.80

2.93

Neurotic, stress-related and somatoform disorders

199

2.36

9.14

1.4

1.5

34.27

38.05

0.29

135

Influenza and pneumonia

219

2.24

9.11

1.3

1.5

42.48

35.72

0.67

144

Condition for Implicit Sepsis (Organ dysfunction codes)

184

2.42

9.10

1.3

1.5

38.18

38.65

0.03

124

155

2.46

9.07

1.3

1.6

41.21

36.62

0.36

104

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

155

2.46

9.07

1.3

1.6

41.21

36.62

0.36

104

Convulsions, not elsewhere classified

4.94

8.91

1.9

1.3

43.29

30.67

0.47

Anxiety disorders

201

2.32

8.86

1.4

1.5

34.27

38.09

0.30

137

Complications of medical and surgical care

211

2.44

8.78

1.9

1.4

42.91

37.44

0.44

135

Other medical care

122

2.88

8.39

1.4

1.3

35.09

39.17

0.20

Bacterial infection, other or unspecified

137

2.73

8.31

1.3

1.5

42.74

40.35

0.12

Any death

135

2.60

8.27

1.5

38.05

39.61

0.08

Other bacterial diseases

206

2.22

8.07

1.4

1.5

39.17

39.57

0.02

136

Dementia

3.25

8.05

1.1

1.4

45.00

44.05

0.03

Bacterial infection, other or unspecified

146

2.61

7.96

1.3

1.5

41.59

40.75

0.04

Myalgia

4.26

7.92

1.2

1.3

36.50

34.52

0.06

First line medication for Crohn's disease

191

2.15

7.92

1.4

33.19

39.37

0.53

122

Complications of procedures, not elsewhere classified

219

2.27

7.87

1.8

1.4

42.79

36.17

0.57

140

COPD/asthma related infections

155

2.23

7.67

1.3

1.6

33.72

36.62

0.21

104

COPD/asthma/ILD related infections

155

2.23

7.67

1.3

1.6

33.72

36.62

0.21

104

Mood disorders, excluding more controls

162

2.29

7.66

1.3

1.5

43.97

37.05

0.53

113

Migraine without aura

4.51

7.63

2.0

1.8

41.00

28.55

0.65

Depression or dysthymia

2.76

7.54

1.2

1.5

41.08

29.56

0.72

Extrapyramidal and movement disorders

3.10

7.53

1.0

1.5

42.78

33.61

0.45

Other reaction to severe stress, and adjustment disorders

3.10

7.53

2.1

1.4

20.70

35.09

1.28

Other antidepressants

154

2.23

7.50

1.3

1.5

40.25

35.23

0.36

103

Recurrent or chronic depression

3.34

7.47

1.2

1.6

40.29

29.09

0.53

Any gastric operation

2.72

7.45

1.6

1.3

34.77

32.32

0.12

GASTRO-related operations

2.72

7.45

1.6

1.3

34.77

32.32

0.12

Asthma (only as main-diagnosis)

116

2.50

7.38

1.3

1.6

45.17

38.44

0.46

Cardiovascular diseases (excluding rheumatic etc)

2.77

7.36

1.9

1.2

37.06

22.02

1.29

Other special examinations and investigations of persons without complaint or reported diagnosis

2.96

7.29

1.3

1.4

34.68

35.56

0.04

Psychiatric diseases

136

2.28

7.29

1.5

1.6

35.15

37.43

0.14

Spondylopathies

136

2.37

7.26

1.6

1.5

37.31

40.63

0.20

Migraine with aura

3.93

7.14

1.5

1.6

37.93

32.11

0.25

Any mental disorder

164

2.14

7.08

1.4

1.5

37.09

36.73

0.02

114

Viral infections characterized by skin and mucous membrane lesions

238

2.16

7.06

1.3

1.5

31.00

40.15

1.09

153

Conjunctivitis (acute, non atopic)

3.32

7.04

1.1

1.4

23.36

31.44

0.40

Asthma (only as main-diagnosis), excluding more controls

114

2.46

7.01

1.3

1.6

43.85

37.16

0.45

All pneumoniae

223

2.07

6.94

1.3

1.5

43.27

36.10

0.70

146

Other disorders of fluid, electrolyte and acid-base balance

3.14

6.87

1.1

1.4

43.14

37.62

0.20

Pneumonia, organism unspecified

208

2.12

6.86

1.3

1.5

43.40

36.90

0.58

135

Implicit bacterial Sepsis

3.03

6.83

1.4

1.5

40.86

36.78

0.18

Lyme disease

3.25

6.81

1.5

1.4

11.70

36.98

2.99

Other spirochaetal diseases

3.25

6.81

1.5

1.4

11.70

36.98

2.99

Care involving use of rehabilitation procedures

185

2.34

6.80

1.7

1.4

40.91

37.24

0.23

123

Dementia, including avohilmo

2.80

6.76

1.1

1.5

46.55

43.69

0.12

Pneumonias (Asthma/COPD co-morbidities)

223

2.05

6.69

1.3

1.5

43.27

35.88

0.73

145

Any dementia, excluding more controls

3.26

6.69

1.0

1.4

53.38

38.39

0.73

Injuries to the abdomen, lower back, lumbar spine and pelvis

103

2.88

6.68

1.4

48.21

31.94

1.05

Hypo-osmolality and hyponatraemia

4.23

6.68

1.1

1.3

42.33

42.56

—

Spirochaetal infections, other/unspecified

3.21

6.68

1.5

1.4

11.70

36.89

3.03

Hypertensive diseases (excluding secondary)

2.95

6.63

1.9

1.3

42.08

17.72

2.26

Alzheimer’s disease, strict definition

4.02

6.62

1.1

1.2

50.10

47.50

—

Ischaemic Stroke, excluding all haemorrhages

117

2.55

6.61

1.9

1.5

41.85

41.18

0.03

Diseases of the eye and adnexa

101

2.43

6.61

1.6

1.5

29.00

36.79

0.53

Disorders of optic nerve and visual pathways

7.80

6.60

1.1

1.3

20.13

43.92

—

Other spirochaetal diseases

3.13

6.42

1.5

1.4

11.70

36.17

2.92

Nausea and vomiting

3.49

6.35

2.6

1.2

25.13

33.51

0.44

Any dementia

3.13

6.30

1.0

1.3

53.37

41.08

0.55

Viral infections characterized by skin and mucous membrane lesions

114

2.72

6.24

1.3

1.4

31.52

33.59

0.11

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

225

2.00

6.16

1.3

1.5

42.38

36.70

0.51

146

Shoulder lesions

142

2.22

6.12

1.8

1.5

41.96

37.84

0.23

101

Migraine without aura and triptan purchases

4.11

6.08

2.1

1.7

44.09

36.17

0.31

Other extrapyramidal and movement disorders in other diseases

3.75

6.07

1.0

1.6

42.25

36.12

0.19

Rotator cuff syndrome

131

2.36

6.04

1.7

1.4

39.41

38.99

0.02

Alzheimer disease, including avohilmo

3.25

5.98

1.1

1.3

46.23

42.09

0.12

All influenza

3.34

5.98

1.2

1.6

32.08

32.16

0.00

Other disorders of urethra and urinary system

151

2.25

5.95

1.4

42.68

30.99

1.06

Unspecific neurodegenerative disorder

2.87

5.89

1.1

1.5

48.33

43.24

0.18

Alzheimer disease

3.49

5.88

1.0

1.3

53.55

45.26

0.25

Asthma (mode)

116

2.26

5.84

1.3

1.6

41.37

38.44

0.17

Dorsopathies

157

2.04

5.78

1.4

1.5

34.43

38.32

0.24

110

Other intervertebral disc disorders

145

2.16

5.75

1.8

1.5

37.72

39.35

0.09

Disturbances of skin sensation

3.07

5.75

1.1

1.5

26.50

32.22

0.27

189

1.94

5.73

1.4

1.5

35.70

37.26

0.10

129

Disorders of vitreous body and globe

149

2.39

5.71

1.4

1.6

45.76

41.13

0.26

100

Bacterial Sepsis

101

2.62

5.67

1.4

1.5

39.09

37.35

0.07

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.90

5.65

2.4

1.3

29.13

19.72

0.47

Anxiety (asthma-related co-morbidities)

133

2.33

5.59

1.1

1.6

36.71

32.98

0.19

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

187

2.22

5.53

1.9

1.4

44.03

36.50

0.58

119

Degenerative diseases of the nervous system

3.23

5.52

1.0

1.2

50.25

44.93

0.16

Pain in joint

2.60

5.51

1.4

1.5

30.76

40.65

0.55

Autoimmune diseases

182

1.93

5.46

1.7

1.4

29.70

40.69

1.19

115

Selective serotonin reuptake inhibitors

155

2.02

5.44

1.4

1.5

40.05

35.69

0.28

104

Parasetamol

2.39

5.42

1.2

1.3

30.46

33.15

0.13

Strabismus

3.22

5.41

1.3

1.5

32.47

32.20

0.01

Hypertension, essential

143

2.10

5.40

1.6

1.4

40.03

36.00

0.26

Zoster [herpes zoster]

145

2.38

5.40

1.5

1.4

29.24

39.51

0.87

Disorders of vitreous body

148

2.35

5.40

1.4

1.6

47.67

41.13

0.39

100

Oral corticosteroids

212

1.90

5.40

1.3

1.5

38.77

37.35

0.09

139

Depression

222

1.92

5.32

1.3

1.5

42.69

36.19

0.50

155

Asthma

116

2.17

5.21

1.4

1.6

43.14

38.44

0.29

Disorders of the thyroid gland

202

1.93

5.12

1.5

43.27

36.30

0.56

134

Mood [affective] disorders

229

1.87

5.08

1.3

1.5

41.88

37.38

0.33

160

Used for control exclusion in common control thyroid runs

168

1.93

5.06

1.6

1.4

29.02

41.42

1.42

106

Mood disorders

229

1.86

5.06

1.3

1.5

41.88

37.38

0.33

160

All anxiety disorders

143

2.21

5.03

1.1

1.5

36.71

35.95

0.03

100

Superficial injury of head

3.40

5.01

1.6

1.5

56.64

33.52

1.15

Asthma, excluding more controls

114

2.15

5.00

1.4

1.6

41.88

37.16

0.29

Abdominal and pelvic pain

154

1.96

4.97

1.5

1.4

33.56

40.44

0.47

112

Persons encountering health services for examination and investigation

2.55

4.96

1.2

1.4

35.74

35.56

0.01

Hypertensive diseases

145

2.02

4.87

1.7

1.5

40.38

36.44

0.25

Other bacterial intestinal infections

3.34

4.87

1.6

1.5

41.50

37.00

—

Hypertension

145

2.02

4.87

1.7

1.5

40.38

36.44

0.25

Metabolic disorders

192

1.91

4.86

1.4

1.5

32.31

39.51

0.60

140

ILD medications

208

1.82

4.83

1.2

1.5

34.98

38.90

0.28

136

Hypothyroidism, other/unspecified

191

1.93

4.77

1.5

39.62

35.63

0.26

126

Dementia in Alzheimer disease

4.93

4.75

1.1

1.2

55.67

42.92

—

Symptoms and signs involving the digestive system and abdomen

154

1.92

4.66

1.5

1.4

30.85

40.44

0.72

112

Inflammatory bowel disease treatment related agents

218

1.80

4.65

1.3

1.5

35.75

37.49

0.11

142

Pain (limb, back, neck, head abdominally)

2.29

4.65

1.2

1.5

35.25

40.65

0.26

Viral pneumonia

5.01

4.62

1.5

1.1

58.25

30.83

—

Pain in thoracic spine

5.01

4.62

1.1

1.3

49.00

36.29

—

Depression medications

4.19

4.62

1.1

43.60

20.36

—

Diseases of the myoneural junction and muscle

5.46

4.59

1.0

1.2

52.71

32.75

—

Somatoform disorder

4.52

4.55

1.2

1.3

49.44

33.78

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

199

1.88

4.53

1.5

40.02

36.22

0.25

131

Asthma-related pneumonia

2.64

4.45

1.1

1.5

42.41

30.25

0.68

Other bacterial intestinal infections

4.38

4.43

1.6

1.2

41.56

39.95

—

Subjective visual disturbances

3.00

4.39

1.3

1.2

33.38

41.55

—

Asthma, hospital admissions , main diagnosis only

238

1.89

4.38

1.3

1.5

45.17

36.35

0.73

160

Liquid cancers, helper endpoint

107

2.37

4.38

1.4

24.09

45.54

2.03

Asthma, hospital admissions 3, pneumonia

2.61

4.36

1.1

1.5

42.41

30.67

0.66

Asthma-related pneumonia or sepsis

2.61

4.36

1.1

1.5

42.41

30.67

0.66

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.99

4.35

1.4

1.3

37.46

34.00

0.11

Ectopic pregnancy

3.20

4.33

2.2

1.4

32.20

33.51

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

183

2.07

4.32

2.0

1.4

44.38

38.09

0.45

117

Autoimmune diseases related-to ILD

245

1.85

4.26

1.2

1.5

26.36

41.27

1.83

162

Fracture of skull and facial bones

3.14

4.20

1.1

1.3

35.82

31.71

0.11

Asthma, hospital admission 2, infections

175

2.07

4.18

1.3

1.5

42.00

35.82

0.40

114

Asthma-related infections

175

2.07

4.18

1.3

1.5

42.00

35.82

0.40

114

Disorders of ocular muscles, binocular movement, accommodation and refraction

132

2.25

4.18

1.3

1.4

26.26

35.91

0.62

Spinal stenosis

104

2.26

4.14

1.4

36.00

44.30

0.42

Septicaemia

107

2.36

4.13

1.5

37.71

41.54

0.16

Diarrhoea and gastroenteritis of presumed infectious origin

199

1.95

4.06

1.3

1.5

40.23

37.55

0.13

126

Explicit Sepsis

102

2.38

4.06

1.5

34.95

35.78

0.03

Other septicaemia

2.46

4.02

1.3

1.4

36.47

43.32

0.29

Diseases of the ear and mastoid process

193

1.74

3.99

1.3

1.6

37.04

37.18

0.01

129

Percutaneous Coronary Intervention

154

1.91

3.99

1.2

1.6

36.85

39.12

0.13

104

Intestinal infectious diseases

243

1.78

3.98

1.4

1.5

41.95

37.82

0.27

162

Non-allergic asthma (mode)

3.30

3.97

1.1

1.6

66.33

30.29

—

Alzheimer’s disease (Late onset)

3.37

3.92

1.1

1.2

40.88

43.74

—

Acute sinusitis

139

2.13

3.88

1.3

1.5

26.12

35.19

0.50

Benign neoplasm: Cerebral meninges

4.79

3.86

1.4

1.3

22.00

42.63

0.86

Benign neoplasm of meninges

4.79

3.86

1.4

1.3

22.00

42.62

0.86

Diplopia

4.79

3.86

3.3

1.2

12.33

42.69

—

Cystitis

160

1.86

3.81

1.9

1.4

44.92

30.66

1.46

102

Rheumatism, unspecified

4.29

3.81

1.0

1.3

28.14

44.05

—

Syncope and collapse

2.46

3.80

1.5

1.3

34.21

36.69

0.08

Oxicams

3.41

3.79

1.3

19.67

40.71

—

Autoimmune diseases excluding thyroid diseases

182

1.77

3.79

1.7

1.4

32.24

40.69

0.76

115

ILD medications: prednisolone, methylprednisolone, prednisone

204

1.73

3.76

1.3

1.5

38.12

38.78

0.04

134

Hypothyroidism, strict autoimmune

142

1.95

3.75

1.4

38.58

39.14

0.03

Dermatitis

208

1.92

3.71

1.5

37.62

38.88

0.07

137

Coronary revascularization (ANGIO or CABG)

154

1.87

3.68

1.2

1.6

36.85

39.12

0.13

104

Other disorders of lacrimal gland

2.37

3.64

1.0

1.5

38.09

37.90

0.01

Non-allergic asthma (mode), excluding more controls

3.08

3.58

1.1

1.6

66.33

33.38

—

Emergency coronary revascularization (for ACS)

164

1.82

3.53

1.2

1.5

37.31

40.94

0.23

111

Transient ischemic attack

120

2.09

3.52

1.3

1.4

41.13

40.03

0.05

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.05

3.52

1.2

1.4

44.27

42.14

0.05

Benzodiazepine use

239

1.70

3.50

1.4

1.5

48.38

35.46

1.40

158

Other and unspecified disorders of vitreous body

130

2.13

3.44

1.4

1.6

40.17

41.03

0.04

Other and unspecified dermatitis

166

1.99

3.42

1.5

34.83

36.30

0.07

109

Lumbar disc prolapse

141

1.96

3.41

1.3

1.5

45.04

39.76

0.28

Diseases of the digestive system

132

2.11

3.39

1.8

1.3

37.38

37.64

0.01

Phobic anxiety disorders

4.07

3.38

1.1

1.2

35.40

28.73

—

Cardiovascular diseases

2.20

3.37

1.6

1.2

41.86

18.73

1.79

Finngen Rheumatological endpoints

185

1.72

3.36

1.7

1.4

31.35

37.79

0.49

126

Acute upper respiratory infections

220

1.68

3.36

1.5

1.4

32.51

39.30

0.60

151

Major coronary heart disease event

162

1.79

3.31

1.2

1.6

38.94

40.69

0.10

110

Other heart diseases

2.30

3.28

1.2

1.3

60.38

21.29

2.78

Fracture of lumbar spine and pelvis

3.02

3.23

1.2

1.6

59.38

35.33

—

Intestinal infectious diseases

232

1.63

3.22

1.3

1.5

40.80

37.58

0.22

154

Fall on same level

217

1.64

3.22

1.3

1.5

37.23

35.57

0.10

148

Soft tissue disorders

165

1.72

3.20

1.6

1.4

31.79

37.22

0.38

117

Congenital malformations, deformations and chromosomal abnormalities

170

1.90

3.12

2.4

1.4

34.50

33.26

0.06

115

Cardiac arrhythmias

2.07

3.10

1.1

1.3

46.80

26.14

1.26

Trochanteric bursitis

3.67

3.08

1.2

1.3

56.00

41.55

—

Codeine

173

1.70

3.07

1.5

36.52

36.25

0.01

122

Chronic apical periodontitis

226

1.61

3.05

1.5

39.20

37.48

0.11

151

Use of anticholinesterases

2.49

3.03

1.1

1.3

56.45

39.12

0.73

N06DA Anticholinesterases

2.49

3.03

1.1

1.3

56.45

39.12

0.73

Disorders of synovium and tendon

139

1.95

3.03

1.5

38.48

35.70

0.14

Autoimmune diseases excluding thyroid diseases, strict definition

176

1.68

2.99

1.8

1.4

28.54

40.87

1.24

110

Viral haemorrhagic fevers, not elsewhere classified/unspecified

3.55

2.98

1.2

1.3

41.83

34.11

—

Other disorders of ear

203

1.68

2.97

1.3

1.5

35.73

38.53

0.17

137

Other and unspecified tonsillitis

2.30

2.91

1.3

36.14

32.76

0.14

Use of other anti-dementia drugs

2.76

2.89

1.1

1.2

39.00

39.44

—

Use of memantine

2.76

2.89

1.1

1.2

39.00

39.44

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

3.44

2.89

1.2

1.3

41.83

36.40

—

Acute suppurative otitis media

2.53

2.89

1.2

1.3

14.64

32.69

1.29

Covid-19 confirmed case

2.21

2.88

1.6

1.5

36.64

34.05

0.09

Codeine or tramadol medication

221

1.58

2.84

1.6

1.4

38.10

37.41

0.04

152

Other anxiety disorders

105

2.06

2.84

1.1

1.4

21.15

33.25

0.72

Pure hypercholesterolaemia

156

1.76

2.83

1.5

34.63

40.50

0.35

111

All kidney diseases

238

1.61

2.77

1.3

1.5

38.65

37.52

0.07

154

Infections of the skin and subcutaneous tissue

178

1.84

2.77

1.3

1.4

30.33

39.61

0.55

117

Diseases of the musculoskeletal system and connective tissue

2.04

2.72

1.1

1.4

37.47

36.59

0.03

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2.28

2.67

1.4

1.5

37.46

33.43

0.13

Diarrhoea and gastroenteritis of presumed infectious origin

232

1.59

2.65

1.3

1.5

37.40

37.58

0.01

154

Substance abuse, excluding more controls

124

1.93

2.65

1.4

1.5

26.94

37.16

0.58

Candidiasis

2.33

2.64

1.4

33.33

36.48

0.11

Fall on and from stairs and steps

2.39

2.62

1.1

1.4

38.60

31.12

—

Disorders of other endocrine glands

131

1.95

2.62

1.7

1.4

56.55

32.99

2.06

Other diseases of urinary system

184

1.62

2.61

1.6

1.4

40.38

32.21

0.62

120

Spondylosis

119

1.92

2.60

1.8

1.4

45.06

42.50

0.11

ILD medications: immunosuppressive drugs

192

1.74

2.54

1.3

1.5

28.29

39.85

0.93

124

Conductive and sensorineural hearing loss

178

1.67

2.53

1.3

1.5

37.87

39.95

0.11

119

Kela-code for severe mental illness

101

2.08

2.52

1.0

1.4

42.50

32.97

0.38

Fall on same level involving ice and snow

186

1.77

2.51

1.4

1.5

53.67

33.52

2.10

124

Other specific joint derangements/joint disorders

146

1.73

2.51

1.4

1.3

30.74

35.99

0.28

Hypothyroidism, strict autoimmune, 3 medication purchases required

189

1.64

2.51

1.4

1.5

36.90

36.04

0.05

123

Ischemic heart diseases

158

1.67

2.50

1.2

1.6

40.39

39.01

0.07

108

Visual field defects

4.38

2.47

1.6

1.3

43.57

43.56

—

Certain infectious and parasitic diseases

1.81

2.47

1.3

1.7

28.22

44.35

1.16

122

1.95

2.44

1.5

40.88

29.78

0.67

Osteopathies and chondropathies

161

1.79

2.43

1.4

38.41

37.12

0.06

107

Cervicalgia

2.90

2.41

1.7

1.3

71.00

36.78

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.25

2.39

1.1

1.4

43.64

32.53

0.46

Unspecified mental disorder

117

1.97

2.39

1.0

1.5

41.94

33.23

0.38

Temporomandibular joint disorders, including avohilmo

130

1.90

2.35

1.6

1.5

36.56

33.39

0.15

Open wound of head

141

1.85

2.33

1.3

1.5

33.86

39.02

0.24

Disorders of sclera, cornea, iris and ciliary body

176

1.76

2.33

1.3

1.5

26.79

38.54

0.93

119

Opioids

175

1.57

2.32

1.5

34.11

36.05

0.11

123

Non-selective monoamine reuptake inhibitors

2.05

2.32

2.3

1.4

52.07

35.95

0.90

Symptoms and signs involving the skin and subcutaneous tissue

232

1.65

2.29

1.6

1.5

32.63

37.76

0.33

155

Disorders of vestibular function (Vertigo)

138

1.85

2.29

1.3

1.5

38.12

36.91

0.05

Nerve, nerve root and plexus disorders

229

1.52

2.27

1.7

1.4

37.69

37.48

0.01

150

Other/unspecified dorsalgia

2.07

2.27

1.5

1.4

51.08

38.08

0.60

Genitourinary diseases

1.83

2.24

1.2

1.4

36.05

35.27

0.03

Oedema, not elsewhere classified

2.34

2.22

1.1

1.3

35.00

36.37

—

Congenital malformations, deformations and chromosomal abnormalities

199

1.67

2.21

2.3

1.4

36.04

34.09

0.10

137

Sulfasalazine

2.19

2.20

1.5

22.73

29.24

0.28

Angina pectoris

117

1.77

2.20

1.2

1.6

40.44

37.51

0.12

Antihypertensive medication - note that there are other indications

1.83

2.18

1.4

41.09

28.30

0.77

Otitis externa

2.50

2.18

1.1

1.6

21.60

30.75

—

Asthma, including avohilmo

235

1.48

2.14

1.3

1.5

39.93

37.05

0.19

156

Sensorineural hearing loss

167

1.63

2.14

1.4

1.5

35.89

39.36

0.19

111

Carpal tunnel syndrome

172

1.69

2.13

1.7

1.4

48.96

37.94

0.74

110

Disorders of lacrimal system

137

1.82

2.11

1.0

1.5

40.83

37.31

0.12

Conjunctivitis

215

1.59

2.10

1.2

1.5

35.45

36.55

0.05

152

Schizophrenia or delusion, excluding more controls

2.15

1.99

1.1

1.4

24.10

33.77

—

Benign paroxysmal vertigo

2.14

1.98

1.3

1.4

33.10

38.93

—

Alcohol use disorder, ICD-based

119

1.85

1.96

1.5

27.21

33.63

0.27

Endocrine, nutritional and metabolic diseases

118

1.63

1.96

1.6

1.4

32.81

37.41

0.24

Suppurative and unspecified otitis media

1.96

1.95

1.2

1.6

19.67

34.32

0.89

Keratitis

105

1.91

1.95

1.2

1.4

31.27

31.61

0.01

Diseases of external ear

1.98

1.94

1.1

1.4

51.82

28.60

1.08

Ulcer of oesophagus

4.55

1.94

1.6

1.3

44.00

34.40

—

Disorders of lipoprotein metabolism and other lipidaemias

166

1.57

1.93

1.6

1.5

30.80

41.65

0.88

120

Any reimbursement code in KELA

1.78

1.93

1.2

1.5

24.95

39.93

0.93

Other disorders of skin and subcutaneous tissue

200

1.60

1.92

1.3

1.5

29.39

41.22

0.80

136

Disorders of conjunctiva

231

1.53

1.91

1.2

1.5

36.32

36.94

0.03

161

Diseases of inner ear

159

1.70

1.91

1.3

1.4

41.05

39.28

0.07

103

Exposure to other specified factors

237

1.55

1.88

1.5

37.14

37.82

0.03

163

Abnormalities of breathing

175

1.53

1.88

1.4

30.59

37.02

0.45

120

HSIL lesion of the cervix uteri

0.00

1.88

0.0

1.6

—

31.05

—

Tramadol

162

1.55

1.84

1.4

1.5

47.29

37.55

0.82

114

Erysipelas

173

1.59

1.83

1.4

1.5

39.25

40.19

0.04

113

Disorders of eyelid, lacrimal system and orbit

221

1.51

1.81

1.2

1.5

40.50

38.70

0.09

150

Other joint disorders

147

1.54

1.81

1.4

1.3

29.54

35.99

0.45

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.06

1.80

1.0

1.5

45.83

31.86

—

Arthropathies

147

1.52

1.72

1.7

1.3

27.53

35.99

0.66

Chronic lower respiratory diseases

234

1.41

1.72

1.3

1.5

38.39

37.45

0.06

154

Dyspnoea

230

1.48

1.71

1.6

1.4

37.37

37.71

0.02

151

Pain in throat and chest

171

1.51

1.71

1.3

1.4

41.42

37.57

0.23

117

Provisional assignment of new diseases of uncertain etiology

163

1.65

1.69

1.5

1.4

34.39

35.18

0.03

105

Injury, poisoning and certain other consequences of external causes

1.80

1.68

1.1

1.4

50.21

30.40

1.09

Sleep disorders

226

1.47

1.67

1.3

1.5

41.23

35.82

0.38

152

Benign mammary dysplasia

2.50

1.66

1.9

1.6

39.00

42.46

—

Soft tissue disorders related to use, overuse and pressure

2.03

1.64

1.1

1.3

58.50

40.09

—

Benign neoplasm: Sigmoid colon

2.44

1.64

1.3

25.00

41.63

—

Behavioural syndromes associated with physiological disturbances and physical factors

229

1.46

1.63

1.3

1.5

41.58

36.23

0.40

154

Codes for special purposes

165

1.63

1.5

1.4

34.39

35.20

0.03

107

Asthma (diagnoses ohter than nonallergic)

249

1.47

1.62

1.4

1.5

45.59

35.35

0.93

159

Renal tubulo-interstitial diseases

229

1.46

1.62

1.3

1.5

39.88

37.04

0.17

149

Personality disorders, excluding more controls

2.06

1.59

1.0

1.3

44.43

32.53

—

Polyarthropathies

133

1.57

1.56

1.7

1.3

29.04

35.83

0.40

Dentofacial anomalies [including malocclusion]

185

1.52

1.53

1.5

36.46

33.50

0.17

123

Exclusions for E4_PCOS_CONSORTIUM

153

1.51

1.53

2.2

1.4

46.31

35.36

0.80

104

Benign neoplasm of brain and other parts of central nervous system

3.34

1.52

2.0

1.3

35.60

43.33

—

Ovarian cyst

1.74

1.51

2.0

1.4

22.33

43.69

1.49

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.90

1.49

1.1

1.5

16.29

33.66

—

Injuries to the thorax

131

1.68

1.48

1.1

1.5

55.80

33.84

1.40

Injury of muscle and tendon at shoulder and upper arm level

101

1.78

1.48

1.4

1.5

54.63

37.25

—

Mycoses

260

1.44

1.47

1.4

1.5

31.74

39.11

0.58

176

Gonarthrosis [arthrosis of knee](FG)

143

1.50

1.47

1.5

1.4

27.12

39.03

0.86

Caries of dentine

2.14

1.47

1.6

1.4

52.67

35.74

—

Sleep apnoea

219

1.42

1.46

1.3

1.5

30.73

40.14

0.82

152

Nontoxic multinodular goitre

2.12

1.44

1.2

1.6

28.17

42.41

—

Diseases of the skin and subcutaneous tissue

190

1.40

1.43

1.3

1.5

20.71

43.95

3.70

128

Venous thromboembolism

158

1.59

1.43

1.2

1.5

33.53

38.70

0.23

102

Sleep apnoea, including avohilmo

221

1.40

1.42

1.3

1.5

32.26

39.88

0.60

154

Asthma/COPD (KELA code 203)

234

1.41

1.42

1.4

1.5

44.03

37.45

0.45

154

Fracture at wrist and hand level

1.79

1.41

1.4

1.5

43.17

31.68

0.45

Propionic acid derivatives

2.16

1.41

1.3

33.50

43.25

—

Injuries to the shoulder and upper arm

236

1.43

1.41

1.4

1.5

38.55

39.35

0.03

167

Schizophrenia, schizotypal and delusional disorders

1.82

1.41

1.1

1.4

29.91

32.30

0.08

Dental caries

2.02

1.40

1.6

1.4

52.67

39.25

—

Urticaria and erythema

103

1.75

1.40

1.3

1.4

33.62

34.70

0.04

Dental pulpitis, including avohilmo

211

1.41

1.39

1.5

42.27

33.74

0.67

142

Mental and behavioural disorders due to alcohol

151

1.59

1.39

1.4

25.40

37.29

0.63

Obesity, other/unspecified

1.77

1.38

1.5

1.4

23.36

36.52

0.59

Neoplasms

145

1.46

1.38

1.6

1.3

28.68

43.39

1.31

Coxarthrosis [arthrosis of hip](FG)

115

1.59

1.37

2.1

1.3

40.82

42.89

0.08

Gonarthrosis

115

1.54

1.36

1.2

1.3

25.50

37.80

0.83

Other arthrosis

108

1.60

1.36

1.4

1.3

40.50

38.45

0.08

Substance abuse

171

1.54

1.35

1.4

26.94

37.83

0.65

109

Dermatitis and eczema

250

1.36

1.35

1.4

1.5

33.79

39.33

0.44

166

Erysipelas

147

1.56

1.34

1.5

35.61

40.84

0.24

Mental and behavioural disorders due to alcohol, excluding acute intoxication

135

1.62

1.33

1.5

27.21

36.43

0.43

Missing teeth due to accident, extraction or parodontitis

180

1.52

1.32

1.6

1.4

39.53

39.78

0.01

121

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

193

1.48

1.31

1.7

1.4

36.68

40.09

0.17

124

Falls/tendency to fall

189

1.38

1.31

1.2

1.6

39.24

33.30

0.36

129

Insomnia

223

1.40

1.30

1.3

1.5

40.87

36.05

0.34

151

Tinnitus

1.94

1.27

1.5

1.4

24.71

33.61

—

Irregular menses

120

1.58

1.27

2.0

1.4

38.88

33.63

0.24

167

1.52

1.27

1.4

27.63

37.27

0.51

106

Injuries to the knee and lower leg

245

1.34

1.27

1.3

1.5

38.50

38.06

0.02

168

Other arthritis (FG)

1.79

1.26

1.3

1.2

39.30

36.83

—

Statin medication

116

1.50

1.25

2.1

1.5

38.23

32.72

0.27

Gonarthrosis,primary

189

1.40

1.25

1.5

39.35

40.13

0.03

134

Other specified/unspecified arthritis

1.82

1.25

1.2

40.00

38.90

—

Heart failure, not strict

175

1.44

1.25

1.2

1.5

48.00

37.13

0.74

112

Reimbursement for rheumatic diseases

194

1.49

1.24

1.5

25.05

38.57

1.20

131

Symptoms and signs involving speech and voice

1.77

1.22

1.1

1.4

50.78

32.45

—

Exposure to unspecified factor

279

0.67

1.22

1.5

50.05

36.93

0.90

184

Other diseases of oesophagus

2.63

1.21

2.2

1.3

54.80

44.00

—

COPD differential diagnosis

116

1.47

1.21

1.2

1.6

31.17

38.44

0.39

ILD differential diagnosis

116

1.47

1.21

1.2

1.6

31.17

38.44

0.39

Mental and behavioural disorders due to psychoactive substance use

174

1.49

1.20

1.4

26.94

38.17

0.68

111

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

238

1.36

1.19

1.6

1.4

37.12

38.28

0.07

156

Schizophrenia or delusion

1.74

1.18

1.1

1.5

24.10

32.45

—

Unspecified fall

154

1.54

1.18

1.2

1.4

55.73

33.44

1.56

101

Polycystic ovarian syndrome, consortium definition

145

1.43

1.15

1.7

1.5

39.81

37.17

0.12

105

Non-invasive ventilation

0.00

1.14

0.0

1.4

—

14.37

—

Second line medication for Crohn's disease

199

1.46

1.13

1.3

1.5

33.77

35.66

0.09

134

Superficial injury of lower leg

1.85

1.13

1.2

1.5

31.29

32.02

—

Triptan medication for migraine, min. 3 purchases

145

1.47

1.12

1.6

1.5

38.05

33.27

0.26

Alcohol use disorder, Swedish definition

153

1.50

1.11

1.4

1.5

29.47

37.95

0.41

100

Unstable angina pectoris

1.66

1.10

1.4

1.6

57.58

35.28

1.48

Fissure and fistula of anal and rectal regions

1.82

1.08

2.1

1.5

53.43

30.82

—

Symptoms and signs involving the circulatory and respiratory systems

175

1.35

1.07

1.6

1.4

33.59

37.02

0.20

120

Major coronary heart disease event excluding revascularizations

122

1.47

1.06

1.4

1.6

50.50

39.24

0.72

Disorders of adult personality and behaviour

1.71

1.05

1.0

1.5

38.75

29.45

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

221

1.33

1.04

1.9

1.4

38.33

38.04

0.01

150

Acute tubulo-interstitial nephritis

182

1.42

1.03

1.4

44.00

37.14

0.37

118

Ptosis of eyelid

2.27

1.03

2.0

1.3

37.80

40.07

—

172

1.43

1.01

1.4

27.63

37.41

0.52

109

Chronic periodontitis, complicated

188

0.58

1.01

1.4

1.5

38.80

38.28

—

125

Other diseases of upper respiratory tract

207

1.31

1.01

1.5

1.4

29.25

41.06

1.15

141

Oxycodone

103

1.58

1.01

1.6

1.4

42.60

41.75

—

Nontoxic goitre/thyroid nodule

1.69

1.01

1.3

1.5

26.78

42.42

—

Injuries to the hip and thigh

125

1.52

1.01

1.1

1.4

49.29

33.52

0.83

Coxarthrosis

1.51

0.99

2.2

1.3

41.31

41.03

0.01

Personality disorders

1.71

0.98

1.0

1.5

44.43

28.70

—

Uterine polyps

0.00

0.97

0.0

1.3

—

43.04

—

Haemorrhoids and perianal venous thrombosis

100

1.60

0.95

1.2

1.5

39.30

38.70

—

Benign neoplasm of colon, rectum, anus and anal canal

180

1.40

0.93

1.5

27.86

42.60

1.18

115

Other pulmonary diagnosis

119

1.39

0.93

1.2

1.6

34.70

37.95

0.15

Excluding asthma or asthma-COPD overlap

119

1.39

0.93

1.2

1.6

32.52

37.95

0.26

Glaucoma suspect

109

1.56

0.93

1.4

1.5

25.33

37.51

—

Other nutritional deficiencies

212

1.38

0.93

1.6

1.4

27.73

36.98

0.58

139

Other arrhythmias

169

1.38

0.92

1.2

1.6

45.50

35.29

0.65

113

Glaucoma

150

1.43

0.92

1.3

1.5

39.14

39.73

0.02

Other diseases of the digestive system

1.63

0.90

1.3

51.89

37.04

—

Disease of hard tissues of teeth, NOS

1.43

0.89

2.0

1.4

30.25

39.20

0.52

Persons encountering health services in other circumstances

126

1.50

0.89

1.4

1.6

44.92

30.24

0.75

Atrial fibrillation and flutter

1.73

0.88

1.0

1.4

47.00

23.35

—

Colonic or urogenital fistula

1.69

0.88

2.1

1.5

53.43

30.62

—

Cardiomyopathy

1.91

0.88

1.3

1.4

50.63

21.67

—

L04AX Other immunosuppressants

194

1.39

0.87

1.3

1.5

31.19

35.72

0.23

130

Insulin, intermediate and long-acting

172

1.41

0.87

1.8

1.3

48.72

37.50

0.59

110

Diseases of arteries, arterioles and capillaries

162

1.37

0.85

1.4

1.5

50.43

37.78

1.00

104

Malignant neoplasm, wide definition for exclusion

189

1.30

0.84

1.6

1.4

22.69

43.87

2.90

127

Disorders of lens

142

1.36

0.84

1.2

1.6

41.76

41.31

0.02

Type 2 diabetes, wide definition

179

1.32

0.84

1.5

1.4

40.79

40.18

0.03

119

DVT of lower extremities and pulmonary embolism

120

1.49

0.83

1.2

1.4

30.73

36.05

0.18

Disorders of refraction and accommodation

1.69

0.81

1.4

1.5

2.40

30.64

—

Obesity

207

1.35

0.80

1.7

1.4

26.00

35.63

0.60

136

Malignant neoplasm

182

1.30

0.80

1.6

1.5

23.36

43.40

2.46

122

Obesity and other hyperalimentation

207

1.35

0.80

1.7

1.4

26.00

35.62

0.60

136

COPD-related respiratory insufficiency

0.00

0.79

0.0

1.3

—

37.77

—

Carcinoma in situ of cervix uteri

0.00

0.79

0.0

1.2

—

33.60

—

Acute nasopharyngitis (common cold)

0.00

0.79

0.0

1.2

—

37.50

—

Insulin, combination of fast acting with intermediate-acting or long-acting

181

1.36

0.78

1.7

1.4

44.55

37.62

0.34

116

Pedal cyclist injured in noncollision transport accidents

0.00

0.78

0.0

1.2

—

41.81

—

Inguinal hernia

132

1.37

0.77

1.3

1.4

31.80

40.47

0.43

Bronchitis

241

1.25

0.75

1.4

1.5

33.70

37.76

0.27

164

Diseases of middle ear and mastoid

142

1.38

0.75

1.2

1.5

29.53

33.09

0.16

Coronary atherosclerosis

131

1.35

0.74

1.4

1.5

38.50

37.40

0.05

Benign neoplasm: Colon

167

1.37

0.74

1.3

1.5

23.44

41.40

1.59

104

Other heart diseases, wide

202

1.27

0.73

1.1

1.5

48.12

35.80

0.90

137

Single spontaneous delivery

1.46

0.73

1.1

1.3

51.33

38.66

0.49

Symptoms and signs involving the urinary system

206

1.29

0.72

1.7

1.4

42.12

38.91

0.17

136

Ischaemic heart disease, wide definition

167

1.30

0.72

1.2

1.5

36.48

40.29

0.20

113

Glucosamine medication

120

1.40

0.70

1.2

1.5

45.67

39.18

0.26

Cough

119

1.43

0.70

1.6

1.4

52.36

36.16

0.68

Diseases of oesophagus, stomach and duodenum

237

1.24

0.69

1.3

1.5

36.61

37.71

0.06

152

GI-bleeding

1.53

0.68

1.3

54.25

35.72

—

Insulin medication

171

1.33

0.68

1.7

1.4

44.55

37.58

0.34

116

Fracture of rib(s), sternum and thoracic spine

1.56

0.68

1.1

1.5

39.71

30.65

—

Other acute lower respiratory infections

153

1.37

0.68

1.3

1.4

37.69

35.71

0.07

Abnormalities of heart beat

108

1.45

0.67

1.1

1.4

49.00

34.55

—

Diseases of the respiratory system

1.37

0.66

1.3

1.5

41.88

37.10

0.19

Fracture of lower leg, including ankle

186

1.33

0.66

1.3

1.5

44.94

35.52

0.56

127

Disorders of skin appendages

145

1.38

0.65

1.3

1.4

29.58

35.50

0.22

100

Female infertility, cervical, vaginal, other or unspecified origin

1.49

0.63

1.3

1.4

36.13

41.60

—

Senile cataract

131

1.31

0.63

1.2

1.6

41.22

41.51

0.01

Persons encountering health services in other circumstances, wide

230

1.21

0.62

1.3

1.5

43.62

36.71

0.56

155

Triptan medication for migraine, single purchase ok

182

1.26

0.61

1.7

1.4

34.83

37.47

0.13

125

Migraine, single triptan purchase ok & required. ICD-code if available is included

182

1.26

0.61

1.7

1.4

34.83

37.47

0.13

125

Sleep disorders (combined)

216

1.21

0.61

1.4

1.5

32.56

38.16

0.42

148

COPD, hospital admissions

118

0.64

0.61

1.1

1.5

51.67

38.46

—

Acute upper respiratory infections of multiple and unspecified sites

180

1.28

0.60

1.6

1.5

32.05

36.89

0.28

122

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

0.60

0.0

1.3

—

43.00

—

Abnormal spermatozoa

0.00

0.60

0.0

1.2

—

32.27

—

Melanocytic naevi

1.50

0.59

1.3

1.4

17.14

35.67

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

146

1.32

0.59

1.9

1.4

50.73

40.19

0.49

Coxarthrosis, primary

162

1.31

0.59

1.8

1.4

45.19

40.77

0.19

104

Family history of malignant neoplasm

0.00

0.58

0.0

1.2

—

34.00

—

Bitten or struck by other mammals

0.00

0.58

0.0

1.2

—

40.94

—

Early onset COPD, excluding more controls

1.51

0.58

1.1

1.6

52.13

38.41

—

Diseases of pulp and periapical tissues, including avohilmo

196

1.22

0.57

1.3

1.5

36.65

37.65

0.05

130

Inflammatory diseases of female pelvic organs

154

1.29

0.57

1.7

1.5

38.76

37.48

0.05

111

Disorders of breast

151

1.32

0.57

1.4

1.5

31.10

39.48

—

112

Myocardial infarction

1.36

0.57

1.2

1.6

49.75

37.67

0.55

Urticaria

1.48

0.57

1.3

1.4

36.14

33.04

—

Any event in cancer register

197

1.23

0.56

1.7

1.4

26.72

41.85

1.51

126

Diabetic nephropathy, excluding more controls

1.65

0.56

1.0

1.8

68.50

30.17

—

Injuries to the wrist and hand

258

1.21

0.56

1.2

1.5

39.25

38.08

0.05

180

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

115

1.38

0.55

1.1

1.5

39.25

31.55

—

Primary open-angle glaucoma

1.47

0.54

1.2

1.3

44.71

41.15

—

Diabetic nephropathy

1.56

0.53

1.0

1.6

68.50

32.83

—

Vasomotor and allergic rhinitis

106

1.39

0.52

1.7

1.4

38.75

33.70

—

Acute appendicitis, no complications

195

1.28

0.52

1.2

1.5

33.39

36.08

0.12

126

COPD, hospital admissions 1, only main diagnosis

0.60

0.52

1.2

1.5

51.33

40.38

—

Spontaneous abortion

107

0.69

0.52

1.3

1.5

54.17

35.26

—

Appendectomy

222

1.25

0.51

1.2

1.5

43.00

35.76

0.40

149

Delivery

1.36

0.51

1.1

1.3

55.73

38.66

0.71

Persons encountering health services for other counselling and medical advice, not elsewhere classified

230

1.18

0.49

1.5

45.00

36.71

0.71

155

External causes of morbidity and mortality

1.28

0.48

1.9

1.4

48.12

31.20

1.10

Peripheral artery disease

102

1.33

0.46

1.1

1.3

64.64

40.32

1.59

Internal derangement of knee

111

1.34

0.45

1.1

1.3

64.11

37.22

—

Female infertility

1.37

0.44

1.3

1.4

36.13

42.00

—

Dental caries, including avohilmo

136

0.79

0.43

2.0

1.4

34.67

41.60

0.31

Obesity due to excess calories

148

1.28

0.43

1.7

1.4

24.36

34.11

0.48

Budesonide

1.61

0.43

2.6

1.7

52.20

36.37

—

COPD, early/later onset

118

0.71

0.42

1.1

1.5

51.30

38.46

—

Diaphragmatic hernia

113

1.33

0.42

1.1

1.5

42.88

40.08

—

Endometriosis of ovary

1.42

0.42

2.5

1.4

29.88

45.83

—

Aplastic and other anaemias

130

1.29

0.42

1.1

1.5

62.75

36.32

1.57

Atopic dermatitis

151

1.25

0.42

1.2

1.6

26.53

33.01

0.35

104

Disorders of choroid and retina

202

1.20

0.41

1.6

1.4

51.25

37.19

1.25

133

Endometriosis ASRM stages 3,4

1.43

0.41

2.3

1.5

31.90

36.56

—

Abnormal findings on diagnostic imaging of other body structures

1.52

0.41

2.2

1.2

44.40

41.33

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

0.41

0.0

1.3

—

46.11

—

Congenital malformations of the urinary system

0.00

0.41

0.0

1.2

—

44.44

—

Other diseases of stomach and duodenum

0.00

0.41

0.0

1.2

—

48.56

—

Need for other prophylactic measures

0.00

0.41

0.0

1.3

—

35.70

—

Thyrotoxicosis with toxic multinodular goitre

0.00

0.41

0.0

1.3

—

48.33

—

Other sexually transmitted chlamydial diseases

0.00

0.41

0.0

1.1

—

27.27

—

Chronic suppurative otitis media, including avohilmo

0.00

0.41

0.0

1.3

—

36.80

—

Non-small cell lung cancer

0.00

0.41

0.0

1.1

—

33.70

—

Inflammatory disease of cervix uteri

0.00

0.40

0.0

1.2

—

45.36

—

Other diseases of pancreas

0.00

0.40

0.0

1.2

—

46.33

—

Chronic diseases of tonsils and adenoids

179

0.81

0.40

1.3

1.4

30.00

39.61

0.63

123

Other diseases of biliary tract

0.00

0.40

0.0

1.2

—

44.20

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.29

0.39

2.4

1.4

36.50

33.96

0.08

Excessive earwax

173

1.24

0.39

1.2

1.5

40.29

37.26

0.13

116

Varicose veins

154

1.23

0.39

2.3

1.4

39.80

38.07

0.07

105

Pregnancy hypertension

121

1.26

0.34

1.2

1.6

40.00

32.85

—

Other external causes of accidental injury

145

1.17

0.34

1.2

1.6

36.13

34.69

0.06

100

Accidents

145

1.17

0.34

1.2

1.6

36.13

34.69

0.06

100

Intestinal stricture

1.34

0.34

1.3

1.5

34.80

34.04

—

Other and unspecified anaemias

112

1.28

0.34

1.1

1.5

62.44

37.13

—

Other diseases of intestines

224

1.14

0.33

1.1

1.5

25.75

38.76

1.18

152

Other anaemias

112

1.27

0.33

1.1

1.5

62.44

37.13

—

Dislocation, sprain and strain of joints and ligaments of knee

193

1.19

0.33

1.3

1.5

37.33

34.83

0.09

132

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

233

1.15

0.32

1.8

1.4

40.24

36.61

0.19

160

Other (seronegative) rheumatoid arthritis, wide

1.28

0.32

1.7

1.5

13.17

43.28

—

Haemorrhage from respiratory passages

1.27

0.31

1.6

1.3

44.33

36.73

—

Necrosis of pulp, including avohilmo

201

1.19

0.31

1.6

1.4

35.38

34.20

0.04

137

Gestational [pregnancy-induced] hypertension

1.33

0.29

1.1

1.6

32.40

32.70

—

Menorrhagia

1.26

0.29

1.5

1.4

38.86

45.56

—

Use of hypnotics and sedatives

229

1.13

0.29

1.4

1.5

38.44

37.55

0.05

145

Early onset COPD

1.29

0.28

1.1

1.6

52.13

32.61

—

Benign neoplasms

195

1.13

0.27

1.9

1.4

26.10

40.57

1.58

126

Arthrosis

127

1.17

0.27

1.9

1.3

27.47

37.20

0.58

Other maternal disorders predominantly related to pregnancy

122

1.18

0.27

2.3

1.4

37.44

35.58

0.08

Gastrointestinal diseases

114

0.83

0.27

1.1

1.5

28.91

39.14

0.38

Benign lipomatous neoplasm

1.30

0.26

1.4

15.60

35.36

—

Solid cancers, helper endpoint

182

1.14

0.26

1.7

1.5

24.78

43.40

1.79

122

Other chronic obstructive pulmonary disease

105

0.78

0.25

1.1

1.5

51.30

41.40

—

Gastro-oesophageal reflux disease

211

1.14

0.24

1.1

1.5

44.57

39.33

0.27

133

False labour

1.30

0.24

1.8

1.4

36.80

28.91

—

Dental operations

109

0.85

0.22

1.2

1.4

31.18

41.68

0.39

COPD, hospital admission 2, with asthma infections

0.74

0.22

1.0

1.3

49.00

38.21

—

Gingivitis and periodontal diseases

207

0.90

0.22

1.2

1.4

35.96

39.54

0.17

142

Delivery, wide proxy

1.22

0.21

1.1

1.4

57.43

40.17

—

Diabetes medication

231

1.10

0.21

1.7

1.5

38.31

37.24

0.05

158

Benign neoplasm: Tongue

0.00

0.21

0.0

1.3

—

44.60

—

Other and unspecified disease of Bartholin gland

0.00

0.21

0.0

1.3

—

51.40

—

Benign neoplasm of thyroid gland

0.00

0.21

0.0

1.2

—

43.50

—

Temporal arteritis

0.00

0.21

0.0

1.3

—

44.60

—

Giant cell arteritis with polymyalgia rheumatica

0.00

0.21

0.0

1.3

—

44.60

—

Other specified and unspecified disorders of eye and adnexa

0.00

0.21

0.0

1.3

—

38.00

—

Benign neoplasm: Rectosigmoid junction

0.00

0.21

0.0

1.3

—

44.60

—

Giant cell arteritis

0.00

0.21

0.0

1.3

—

51.67

—

Oesophageal varices

0.00

0.21

0.0

1.3

—

44.60

—

Other and unspecified abdominal hernia

0.00

0.21

0.0

1.4

—

34.00

—

Primary angle-closure glaucoma

0.00

0.21

0.0

1.5

—

29.60

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

0.21

0.0

1.3

—

38.00

—

Lesion of lateral popliteal nerve

0.00

0.21

0.0

1.2

—

61.60

—

Other and unspecified coagulation defects

0.00

0.21

0.0

1.1

—

55.00

—

Other disorders of white blood cells

0.00

0.21

0.0

1.2

—

37.50

—

Other obstetric trauma

0.00

0.21

0.0

1.3

—

43.70

—

Osteomyelitis

0.00

0.21

0.0

1.4

—

26.60

—

Other salmonella infections

0.00

0.21

0.0

1.3

—

32.57

—

Secondary right heart disease

0.00

0.21

0.0

1.4

—

37.33

—

Femoral hernia

0.00

0.21

0.0

1.3

—

42.83

—

Other pulmonary heart/vessel disease

0.00

0.21

0.0

1.4

—

37.33

—

Vitamin deficiency, wide

0.00

0.21

0.0

1.3

—

45.00

—

Vitamin deficiency

0.00

0.21

0.0

1.3

—

45.00

—

Cholesteatoma of middle ear

0.00

0.21

0.0

1.2

—

37.17

—

Laparoscopic right hemicolectomy

0.00

0.21

0.0

1.4

—

37.33

—

Cholangitis (primary sclerosing, PSC)

0.00

0.21

0.0

1.3

—

44.71

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

212

1.11

0.21

1.7

1.5

48.36

37.92

0.72

145

Open wound of wrist and hand

132

1.18

0.21

1.4

1.5

43.00

32.54

—

COPD

110

0.82

0.21

1.1

1.6

51.55

41.56

0.52

Hypercalcemia

0.00

0.21

0.0

1.4

—

44.43

—

Other salmonella infections

0.00

0.21

0.0

1.2

—

39.38

—

Pneumothorax

0.00

0.21

0.0

1.2

—

34.20

—

L01XX Other antineoplastic agents

0.00

0.20

0.0

1.4

—

39.13

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

0.20

0.0

1.4

—

32.29

—

Congenital malformations of the urinary system

0.00

0.20

0.0

1.2

—

40.75

—

Intestinal adhesions without obstruction

0.00

0.20

0.0

1.4

—

43.33

—

Chronic suppurative otitis media

0.00

0.20

0.0

1.2

—

40.75

—

Dermatophytosis

211

1.14

0.20

1.2

1.5

33.38

38.38

0.23

147

COPD related to multimorbidity

104

0.81

0.20

1.1

1.5

51.30

38.26

—

Hyperlipidaemia, other/unspecified

108

1.19

0.19

1.2

1.5

46.14

40.07

—

Basal cell carcinoma, including avohilmo

107

0.84

0.19

1.8

1.4

37.00

45.89

—

Primary gonarthrosis, bilateral

149

1.15

0.19

1.5

37.20

41.72

—

103

Injuries to the elbow and forearm

219

0.88

0.19

1.3

1.5

39.25

37.83

0.06

151

Caries of enamel

240

0.90

0.18

1.4

1.5

33.57

37.08

0.16

164

Presence of other functional implants

143

0.87

0.17

1.3

1.4

50.60

38.51

—

Coxarthrosis, primary, with hip surgery

138

1.15

0.17

1.2

1.4

50.75

40.48

0.45

Diabetes mellitus

226

1.09

0.16

1.9

1.4

36.81

37.46

0.03

153

Diseases of pulp and periapical tissues and dental caries

115

0.89

0.14

1.3

1.4

38.75

41.25

0.08

Contraceptive management

1.14

0.14

1.1

1.6

32.55

35.84

0.11

Atherosclerosis, excluding cerebral and coronary sclerosis

1.15

0.14

1.1

1.3

68.00

40.35

—

Artificial joint operation, meniscal resection

219

0.92

0.14

1.5

1.4

49.76

39.40

0.61

151

Persons encountering health services in circumstances related to reproduction

136

0.89

0.13

1.2

1.5

30.50

37.34

0.30

Chronic sinusitis

141

1.13

0.13

1.5

1.4

25.78

38.20

—

Basal cell carcinoma

103

0.87

0.13

1.8

1.4

37.00

47.30

—

Transport accidents

130

1.12

0.13

1.1

1.6

31.44

34.73

—

Cholelithiasis

204

1.08

0.12

1.3

1.5

29.43

40.35

0.73

136

Other (not insulin) diabetes medications

216

1.07

0.12

1.8

1.5

39.69

39.03

0.03

147

Cholecystectomy

206

1.09

0.12

1.2

1.5

27.33

40.40

0.95

136

Constipation

219

1.07

0.11

1.9

1.4

45.11

37.06

0.53

144

Type 2 diabetes

219

1.07

0.11

1.8

1.5

35.27

38.11

0.16

148

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

167

1.11

0.11

1.4

19.75

41.00

1.39

112

Type 2 diabetes, definitions combined

209

1.07

0.11

1.8

1.5

35.96

38.41

0.13

141

Mouth breathing

124

1.13

0.11

1.2

1.5

12.33

35.83

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

133

1.11

0.11

1.2

1.6

40.00

34.95

—

114

1.13

0.10

2.4

1.5

47.89

41.78

—

Acute appendicitis

234

1.08

0.10

1.2

1.5

34.90

36.68

0.08

157

Type 2 diabetes, strict (exclude DM1)

210

1.06

0.10

1.8

1.5

35.96

38.76

0.15

142

Diabetes, varying definitions

227

1.06

0.10

1.9

1.4

36.68

37.48

0.04

154

L02BA Anti-estrogens

1.06

0.09

2.6

1.6

30.60

39.55

—

Cholelithiasis, broad definition with cholecystitis

209

1.06

0.09

1.2

1.5

29.43

40.60

0.76

139

Hernia

241

1.06

0.09

1.3

1.5

37.35

39.75

0.12

168

Pregnancy with abortive outcome

124

0.93

0.08

2.0

1.5

35.53

37.15

0.05

Diverticular disease of intestine

158

0.93

0.08

1.3

1.5

18.17

42.21

1.75

106

Injuries to the ankle and foot

225

1.07

0.08

1.1

1.5

49.81

32.88

0.95

151

Gonarthrosis, primary, with knee surgery

155

1.08

0.08

1.5

32.70

41.27

—

106

Skin changes due to chronic exposure to nonionizing radiation

108

1.11

0.08

1.9

1.4

51.00

42.02

—

Other diseases of pleura

120

1.10

0.07

1.1

1.4

35.00

38.40

—

Artrosis, including avohilmo

168

0.94

0.07

1.9

1.4

26.47

35.83

0.62

115

Pregnancy, childbirth and the puerperium

1.13

0.07

1.2

47.20

40.32

—

Malignant neoplasm of skin

114

1.08

0.07

1.7

1.4

31.40

46.00

—

Diabetes, insulin treatment (Kela reimbursement)

225

1.05

0.06

1.7

1.4

48.36

37.27

0.78

156

Allergic conjunctivitis

188

0.93

0.06

1.4

1.5

46.38

35.49

—

134

Other diseases of hard tissues of teeth

100

0.93

0.06

1.3

1.4

34.69

39.20

0.17

Type 2 diabetes, definitions combined, including avohilmo

213

0.96

0.06

1.9

1.5

33.84

39.60

0.34

144

Heart failure, strict

136

0.93

0.06

1.2

1.5

62.82

40.31

1.20

Disorders of gallbladder, biliary tract and pancreas

236

1.04

0.05

1.2

1.5

31.27

39.94

0.59

156

All-cause Heart Failure

135

0.94

0.04

1.2

1.5

62.82

39.85

1.23

Heart failure,strict

120

0.94

0.04

1.3

1.5

59.30

39.81

—

Other retinal disorders

171

1.05

0.03

1.4

1.5

60.12

35.90

2.07

110

Noninflammatory disorders of female genital tract

0.94

0.03

1.3

24.78

43.69

—

Abnormal findings on diagnostic imaging of lung

145

1.06

0.03

1.1

1.4

28.27

39.47

0.48

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

173

0.95

0.02

1.4

1.5

46.38

36.41

—

123

Valvular heart disease excluding rheumatic fever

106

0.95

0.01

1.4

1.6

43.43

37.97

—

Excessive, frequent and irregular menstruation

0.95

0.01

2.3

1.3

42.13

43.69

—

Chronic periodontitis, including avohilmo

243

1.02

0.01

1.6

1.5

41.29

38.86

0.13

169

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

113

0.96

0.01

1.7

1.4

42.22

45.61

—

Biguanides

217

0.98

0.00

1.8

1.5

35.23

39.43

0.21

148

Appendicitis, broad definition

239

1.02

0.00

1.2

1.5

34.90

36.58

0.07

160

Periodontitis

244

1.01

0.00

1.6

1.5

41.29

39.05

0.12

170

Presence of cardiac and vascular implants and grafts

105

0.99

0.00

1.0

1.4

47.75

39.75

—

Noninfective enteritis and colitis

145

0.96

0.00

1.1

1.4

43.86

32.61

—

Medical abortion

122

1.02

0.00

1.3

1.5

36.87

37.15

0.01

Diseases of appendix

242

1.01

0.00

1.2

1.5

34.90

36.75

0.08

161

Caries of dentine, including avohilmo

147

1.01

0.00

1.8

1.5

31.14

40.43

0.60

102

Other malignant neoplasms of skin (=non-melanoma skin cancer)

106

0.97

0.00

1.7

1.4

39.13

46.59

—

Myocardial infarction, strict

0.99

0.00

1.2

1.6

42.25

37.05

—

Non-rheumatic valve diseases

105

0.96

0.00

1.4

1.6

43.43

37.92

—

Diseases of oral cavity, salivary glands and jaws

100

0.98

0.00

1.2

1.4

37.44

39.20

—

Unspecified haematuria

108

1.00

0.00

1.2

1.4

43.00

41.89

—

Periapical abscess

147

1.02

0.00

1.2

1.5

18.56

38.29

—

COPD (mode)

0.92

0.00

1.1

1.6

57.75

42.85

—

Endometriosis of intestine

0.00

0.0

1.0

—

35.20

—

Infections of breast associated with childbirth

0.00

0.0

1.0

—

47.14

—

Complications of the puerperium, not elsewhere classified

0.00

-0.00

0.0

1.1

—

35.50

—

Habitual aborter

0.00

-0.00

0.0

1.2

—

42.20

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.88

-0.00

1.0

1.4

42.50

38.97

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Neutrophils/100 leukocytes in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS